Table 1.

Information on patient details used in this study

Sample no.	Age	Menstrual stage	Indication/diagnosis	Assay
1	48	Proliferative	Menorrhagia	M
2	52	Proliferative	Prolapse	M, Q
3	49	Proliferative	Menorrhagia	M, Q
4	52	Proliferative	Fibroids	M, Q
5	45	Secretory	Menorrhagia	M, Q
6	48	Secretory	Fibroids	M, Q
7	30	Secretory	Severe endometriosis	M, Q
8	48	Secretory	Menorrhagia	M, Q
9	55	Post-M	Fibroids	M
10	57	Post-M	Prolapse	M
11	49	Post-M	Unknown	M, Q
12	47	Proliferative	Menorrhagia	Q
13	36	Proliferative	Menorrhagia	Q
14	49	Proliferative	Fibroids	Q
15	40	Proliferative	Fibroids	Q
16	41	Secretory	Prolapse	Q
17	41	Secretory	Prolapse	Q
18	47	Secretory	Prolapse	Q
19	46	Secretory	Menorrhagia	Q
20	53	Post-M	Prolapse	Q
21	54	Post-M	Unknown	Q
22	64	Post-M	Prolapse	Q
23	63	Post-M	Prolapse	Q
24	53	Post-M	Prolapse	Q
25	65	Post-M	Prolapse	Q
26	66	Post-M	Prolapse	Q
27	50	Post-M	Prolapse	Q
28	54	Post-M	Prolapse	Q
29	43	Proliferative	Menorrhagia	I
30	53	Proliferative	Adenomyosis	I
31	49	Proliferative	Adenomyosis	I
32	51	Proliferative	Menorrhagia	I
33	46	Proliferative	Menorrhagia	I
34	39	Secretory	Menorrhagia	I
35	38	Secretory	Adenomyosis	I
36	48	Secretory	Menorrhagia	I
37	43	Secretory	Adenomyosis	I
38	53	Post-M	Prolapse	I
39	65	Post-M	Prolapse	I
40	70	Post-M	Prolapse	I

M, Microarray; Q, qRT-PCR; I, immunofluorescence.